Researchers reported a method enabling the simultaneous incorporation of up to five distinct noncanonical amino acids (ncAAs) into a single protein in mammalian cells—an advance that broadens the chemical repertoire available for therapeutic proteins and synthetic biology. The work overcomes long‑standing constraints on genetic code expansion and was presented in a recent scientific communication. The technique employs engineered tRNA/synthetase pairs and codon reassignment to insert multiple ncAAs in defined positions, enabling new chemistries for protein labeling, drug conjugation, and novel modalities. Translational groups will assess scalability, fidelity, and immunogenicity before industrial adoption, but the approach could materially expand biologic design space and linker/payload strategies for next‑generation therapeutics.